Background and objective: Determination of asthma phenotypes, particularly inflammatory phenotypes, helps guide treatment and management of this heterogeneous disease. Induced sputum cytology has been the gold standard for determination of inflammatory phenotypes, but sputum induction is fairly invasive and technically challenging. Blood and nasal lavage cytology have been suggested as substitutes, but have not been fully verified. The aim of this study is to determine the accuracy of blood and nasal lavage cytometry as indicators of inflammatory phenotypes in asthma. Methods: Clinical evaluation, Asthma Control Questionnaire (ACQ) and spirometry were performed for 121 adult asthma patients, and blood, nasal lavage and induced sputum samples were taken. Eosinophils and neutrophils were counted in three samples from each subject. Inflammatory phenotypes (eosinophilic, neutrophilic, mixed and paucicellular) and cells counts were analysed using Venn diagram and receiver operating characteristic (ROC) curve, respectively. Results: ACQ score, spirometry and bronchodilator response did not differ among subjects with different inflammatory phenotypes. Inflammatory phenotypes defined by nasal lavage cytometry were in better concordance than those defined by blood cell counts with phenotypes determined by sputum cytology, and were significantly correlated with sputum phenotypes. For eosinophilia, nasal lavage cytology showed better accuracy than blood cytology (area under the curve (AUC): 0.89 vs 0.65). For all phenotypes, sensitivity and positive and negative predictive power were higher for nasal lavage cytometry than for blood. Blood cell counts gave a high level of false positives for all inflammatory phenotypes. Conclusion: We recommend nasal lavage cytology over blood cell count as a substitute for sputum cytology to identify inflammatory phenotypes in asthma.
INTRODUCTION
Asthma is a common chronic disorder of the airways with variable and recurrent symptoms that can be triggered by upper respiratory viral infections, allergen exposure, airway irritants or other environmental, genetic or epigenetic factors. It is characterized by nonspecific bronchial hyper-responsiveness and airway inflammation. 1 Asthmatic patients may show variable wheezing, shortness of breath, chest tightness and/or cough, and variable airflow limitation.
The pathogenesis of asthma is variable and this affects patients' treatment response and prognosis. Multiple studies have revealed the significant heterogeneity possible in severity of airway obstruction and symptoms, degree of reversibility and response to medications in patients with asthma. 2, 3 The cornerstone of asthma treatment is inhaled corticosteroids (ICSs) plus long-acting β2 agonists (LABAs), but a significant
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Airway inflammation is one of the many mechanisms underlying asthma. Many therapies target inflammation. Induced sputum cytology is the gold standard for determining inflammatory phenotypes, but blood cell count is often used as a substitute. We show that nasal lavage cytometry better reflects sputum-based determination of inflammation than blood cell count.
number of patients fail to respond to this treatment. Classification of asthma patients according to asthma phenotype may help clarify pathogenesis and guide treatment decisions, allowing more targeted therapies. Asthma phenotypes can be described in terms of a variety of attributes, including triggering factors, age of onset, pulmonary function, severity, response to treatment and degree and type of inflammation. Determining inflammatory phenotype by quantifying leucocytes in sputum provides insight into underlying pathobiology and informs treatment choices. Inflammation can be described as eosinophilic, neutrophilic, mixed (eosinophilic and neutrophilic) and paucicellular 4 depending on numbers of eosinophils and neutrophils observed. Certain medications have been shown to be particularly effective in asthma patients with an eosinophilic inflammation phenotype. [5] [6] [7] [8] However, sputum collection is not done routinely in clinical practice, due to safety issues and technical difficulties. Nasal lavage cytometry and blood cell count are recommended as substitute methods to evaluate airway inflammation, but these methods have not been fully validated.
The aim of this study is to determine the accuracy of nasal lavage cytometry and blood cell counts, as compared with induced sputum cytology, as indicators of inflammatory phenotypes in asthma.
METHODS

Subjects and study design
This is a cross-sectional study that included 121 subjects over 18 years who had moderate to severe asthma characterized by physician diagnosis of asthma for ≥12 months with spirometry showing obstruction with significant reversibility. They had been treated with ICS plus LABA combination therapy for at least 3 months. The severity was considered moderate to severe when they are under step 4 or 5 therapy of GINA guidelines. 9 All subjects were non-smokers or ex-smokers (<10 pack-years). Only subjects with controlled asthma (Asthma Control Questionnaire (ACQ) score < 1.5) 10, 11 were included. Clinical evaluation, spirometry, 12,13 skin prick test, 14 blood sample and nasal lavage were obtained, followed by sputum induction. All procedures were performed at the same visit.
The Ethics Committee of the Federal University of São Paulo, Hospital São Paulo, approved the protocol and all subjects provided written informed consent before inclusion (CEP1515/08).
Procedures
The atopic status of the subjects was determined using ASAC pharma (Alicante, Spain) skin prick test with 10 common environmental aeroallergens. Atopy was defined as at least one positive reaction obtained (weal at least 3 mm of diameter greater than negative control).
14 Spirometry was performed according to American Thoracic Society criteria and the Brazilian reference values using Koko-PFT System Windows version 4.1.X Spirometer (Longmont, Colorado, USA). 12, 15 Reversibility of airflow limitation was measured by comparing forced expiratory volume in 1 s (FEV 1 ) before and after administration of 400 mcg salbutamol. Reversibility was defined as an increase in post-bronchodilator FEV 1 of more than 12% and 200 mL compared with the prebronchodilator value.
Nasal lavage was performed before sputum induction to avoid hypertonic saline nasal epithelium challenge or induction of chemotactic factor release. Lavage was performed as previously described by instilling 10 mL of 0.9% sterile saline solution (22) (23) (24) (25) (26) (27) (28) C), 5 mL in each nostril, with the subject's head tilted 30 backwards. 12 Subjects were told not to breathe or swallow for approximately 10 s while performing a Valsalva manoeuvre, and then to tilt their head forward and expel the lavage fluid (at least 7 mL) into a sterile container. The collected sample was shaken vigorously and then centrifuged for 15 min at 2500 g and 4 C. The cell pellet was resuspended in 0.5 mL of PBS and total number of cells was determined using a Neubauer haemocytometer. Cell suspension of 200 mL was spun at 36 g for 6 min in a Cytospin 4 Shandon Centrifuge (New York, USA) and the resulting cell smears were stained with Panotics Wright's Stain Kit (Laborclin, Paraná, Brazil). A total of 200 cells were analysed for differential cell count. Cells were identified as epithelial, neutrophil, eosinophil or lymphomononuclear based on morphology. For nasal lavage, the percentage of eosinophil and neutrophil cells was obtained from a total of 200 cells due to the low cell concentration of the final standard sample dilution (500 cells/mL). 13 The nasal samples were considered eosinophilic or neutrophilic when relative cell count was ≥4.5% or ≥50%, respectively. 16, 17 Blood eosinophilia was defined as absolute eosinophil count (eosinophils/mm 3 ) ≥ 220 or relative count ≥ 3% (out of 100 total cells). Neutrophilia was defined by absolute count was ≥ 5000/mm 3 and relative cell count was ≥ 76% (out of 100 total cells), as previously described. 18, 19 Sputum was induced by inhaling increasing concentrations of saline (3%, 4% and 5%) for 7 mineach and processed according to a validated technique. 20, 21 The cells in sputum were stained and eosinophils and neutrophils were counted. 3 Sputum was considered eosinophilic or neutrophilic when relative cell counts were ≥3% or ≥65% (out of 400 total cells), respectively. 22 Mixed inflammatory phenotype was defined as relative sputum eosinophil count ≥3% and relative sputum neutrophil count ≥65%. Paucicellular inflammation was defined as relative eosinophil count <3% and relative neutrophil count <65%.
Statistical analysis
The results are presented as mean, median, SD and interquartile range. The parametric data were compared by analysis of variance (ANOVA), non-parametric by Kruskal-Wallis test and categorical variables were tested by chi-square test. The interclass correlation coefficient (Cronbach's α) was applied for concordance among inflammatory phenotypes determined by sputum, nasal lavage and blood cytology. Spearman's coefficient was used to assess correlation between nasal lavage or blood cell count and sputum count (the gold standard). The receiver operating characteristic (ROC) curve was applied to determine cut-off points for nasal lavage and blood sample cellularity. A P-value <0.05 was considered significant.
RESULTS
Clinical and demographic characteristics of the 121 study subjects are shown in Table 1 . The majority of subjects were females and atopic. They presented with mild to moderate obstruction and positive response to bronchodilators in spirometry.
Although all subjects were under control according to ACQ, and were currently receiving ICS plus LABA combination therapy, 31 subjects (25.6%) presented with eosinophilic inflammation (sputum eosinophil ≥3%), 52 with neutrophilic inflammation (sputum neutrophil ≥65%), 19 had mixed inflammation (sputum eosinophil ≥3% and neutrophil ≥65%) and 19 presented had paucicellular sputum (sputum eosinophil <5% and neutrophil <65%) ( Table 1) .
When subjects' characteristics were considered according to inflammatory phenotype, as defined by sputum cytology, no significant differences were observed ( Table 2) . Of particular note, ACQ score, spirometry and bronchodilator response did not differ among subjects with different inflammatory phenotypes.
To begin to evaluate the accuracy of nasal lavage and blood cytology as compared with sputum cytology in the determination of inflammatory asthma phenotypes, we investigated the concordance among inflammatory phenotypes as defined by sputum, nasal lavage and blood cell counts using Venn diagrams. As shown in Figure 1 , there was better concordance between nasal lavage and induced sputum than blood and induced sputum for all phenotypes except paucicellular phenotype. Blood cell counts gave a high level of false positives for all inflammatory phenotypes.
The sensitivity, specificity and positive and negative predictive value of nasal lavage and blood sample cytology for determining inflammatory phenotypes as defined by sputum cell count are presented in Table 3 . Nasal lavage cytology gave higher values than blood cytology for every measure except specificity for the paucicellular phenotype.
The accuracy of nasal lavage and blood cell counts in predicting sputum eosinophil or neutrophil cell count was further investigated via ROC curve analysis (Fig. 2) . Nasal lavage cytology showed higher accuracy than blood cytology for both eosinophilic and neutrophilic inflammation (area under the curve (AUC): 0.89 vs 0.65 and 0.67 vs 0.60, respectively).
We also evaluated correlation between induced sputum cell counts and nasal lavage or blood cytology (Fig. 3) . While there was significant correlation between sputum cell counts and both nasal lavage cytology and blood cytology for eosinophils and neutrophils, correlation between sputum and nasal lavage eosinophil counts was much higher than between sputum and blood eosinophil counts (0.725 vs 0.321).
DISCUSSION
Clinical data are the basis of asthma diagnosis and management, often combined with lung function tests. Asthma patients may share common functional abnormalities such as airway obstruction or airway hyper-responsiveness, and show similar symptoms, including shortness of breath, chest tightness, wheeze and cough, but have different underlying inflammatory phenotypes. In this study, subjects presented similar symptoms and functional abnormalities, but heterogeneous inflammatory phenotypes. The most prevalent phenotype was neutrophilic inflammation (43%) followed by eosinophilic (25.6%).
Induced sputum is considered the gold standard to assess central airway inflammation. It is a relatively invasive and technically complex technique, and is too variable for routine clinical use. Nevertheless, it became an accepted sampling technique to monitor molecular and cellular events in the central airways, with widespread use in the past 10 years.
The utility of sputum eosinophil counts as a tool to manage asthma has been widely debated. 23, 24 Several studies have shown that better asthma control can be achieved when sputum cytology is used to titrate drug therapy. 22, 25 However, the latest guidelines on asthma management characterized the induced sputum technique as complex and not applicable in clinical practice. 26 This motivated our research on substitute markers. 
Phenotyping asthma
Peripheral blood eosinophilia has been proposed as a potential asthma biomarker. 27 Inflamed tissue releases chemoattractants and cytokines, which recruit immune cells from peripheral blood and bone marrow. The dynamic process of immune cells entering and leaving the blood stream can be used as an indirect readout of tissue inflammation. Blood eosinophil counts have been used to identify patients with moderate to severe uncontrolled asthma, 28 and those who might respond to biologics that target Th2-related While blood eosinophilia has been shown to correlate with bronchial hyper-responsiveness and asthmarelated inflammation, 30 its role as a specific diagnostic measurement for asthma-related inflammation is limited by the fact that blood eosinophilia can have a variety of causes, including allergies, autoimmune disease and parasitic infections.
Recently Katz et al. reported in a post hoc clinical trial analysis that a blood eosinophil count of 150/mm 3 is a useful biological marker to predict a favourable response to anti-IL-5 treatment. 29 Wenzel et al. reported that a blood eosinophil count of 300/mm 3 can help identify patients with uncontrolled moderate-tosevere asthma who will respond to dupilumab, an inhibitor of the IL-4 receptor. 8 The PREDUNA study provides evidence that high eosinophilia in adults with persistent asthma, less well-controlled asthma and higher GINA step-care levels are associated with increased risk of future asthma exacerbations. 31 Nasal lavage cytology is another possible substitute for induced sputum cytology in the determination of asthma inflammatory phenotypes. Nose is an easy and accessible airway that shares aspects of the lower airways; the nasal mucosa is similar to that of the lower airways and inflammatory processes in the nose reflect those in the lower airways. 32, 33 Nasal lavage is a non-invasive and cost-effective procedure. It is well suited for fluid-phase component analysis such as leucocyte cell counts. Few studies have been performed, however, on the use of naval lavage cytology to determine inflammatory phenotypes in asthma. The present study showed that nasal lavage cytology more accurately identifies inflammatory phenotypes as defined by the gold standard induced sputum cytology than blood cell count. ROC analysis clearly showed that nasal lavage cytology identifies eosinophilic inflammation more accurately than blood cell count (AUC: 0.89 vs 0.65). For all phenotypes, sensitivity and positive and negative predictive power were higher for nasal lavage cytometry than for blood.
Further study should be carried out to investigate nasal lavage cytology as a predictor of future risk, exacerbations and loss of lung function in asthma, and to compare outcomes when nasal lavage and blood cytology are used to guide treatment decisions.
In conclusion, based on our results, nasal lavage cytometry shows better accuracy than blood Phenotyping asthma cytology for characterizing asthma inflammation. We recommend the use of nasal lavage cytology rather than blood cell count as an easy and accurate substitute for induced sputum cytology to determine eosinophilia and other inflammatory phenotypes in asthma. 
